Literature DB >> 6306322

Immunohistology of malignant rabbit fibroma virus--a comparative study with rabbit myxoma virus.

D S Strayer, S Sell.   

Abstract

Malignant rabbit fibroma virus (MV) causes a syndrome that consists of disseminated malignant tumors and immunosuppression complicated by severe Pasteurella multocida infection and death. Tissues from rabbits given MV and rabbit myxoma virus were examined by direct immunofluorescence with the use of antibody against virus antigens. Primary and metastatic tumors caused by MV and rabbit myxoma virus were composed of soft tissue cells containing virus antigens. Skin appendages and epidermis overlying the respective tumors showed scant MV but abundant myxoma virus antigen. Both viruses were present systemically in the reticuloendothelial system. Epithelial cells from the liver, kidney, and lung of myxoma virus-infected rabbits contained virus, whereas in MV tumor-bearing rabbits, these cells were uninvolved. However, nasal mucosal and conjunctival epithelia, the locations of Pasteurella infection, showed squamous metaplasia and contained large amounts of MV and myxoma antigens. By analogy to other respiratory tract pathogens, these epithelial changes were probably etiologically significant for development of pasteurellosis in rabbits bearing virus-induced tumors. Thus by immunopathologic as well as clinical examination, MV produces a syndrome distinct from that seen with rabbit myxoma virus. MV induced severe immunosuppression despite T-lymphocyte hyperplasia in the lymphoid tissues observed. The combination of a systemic virus infection, epithelial alterations that impaired clearance mechanisms, and immunologic dysfunction is likely to contribute to the inability of rabbits given MV to survive their gram-negative infection.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6306322

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  9 in total

1.  Malignant rabbit fibroma syndrome. A possible model for acquired immunodeficiency syndrome (AIDS).

Authors:  D S Strayer; S Sell; J L Leibowitz
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

2.  Mapping and sequencing of a gene from myxoma virus that is related to those encoding epidermal growth factor and transforming growth factor alpha.

Authors:  C Upton; J L Macen; G McFadden
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

3.  Inhibition of virus replication does not alter malignant rabbit fibroma virus-induced immunosuppression.

Authors:  D S Strayer; E Skaletsky; J L Leibowitz
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

4.  Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor.

Authors:  A Opgenorth; K Graham; N Nation; D Strayer; G McFadden
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

Review 5.  Vaccinia virus: a suitable vehicle for recombinant vaccines?

Authors:  C Kaplan
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

6.  Strain differences in Shope fibroma virus. An immunopathologic study.

Authors:  D S Strayer; E Skaletsky; S Sell
Journal:  Am J Pathol       Date:  1984-08       Impact factor: 4.307

7.  Syphilis superinfection activates expression of human immunodeficiency virus I in latently infected rabbits.

Authors:  C K Tseng; M A Hughes; P L Hsu; S Mahoney; M Duvic; S Sell
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

Review 8.  Poxvirus pathogenesis.

Authors:  R M Buller; G J Palumbo
Journal:  Microbiol Rev       Date:  1991-03

Review 9.  Myxoma virus and the Leporipoxviruses: an evolutionary paradigm.

Authors:  Peter J Kerr; June Liu; Isabella Cattadori; Elodie Ghedin; Andrew F Read; Edward C Holmes
Journal:  Viruses       Date:  2015-03-06       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.